How Elligo Achieved Enrollment for an Early Cancer Detection Blood Draw Study Despite Barriers
A pharmaceutical company partnered with Elligo Health Research® to recruit participants for a Phase III clinical trial aimed at evaluating the efficacy of CancerSEEK, a revolutionary blood test designed to detect various types of cancer in its early stages. CancerSEEK, often referred to as a liquid biopsy, offers the potential to identify multiple cancers with high accuracy. This case study highlights the success of a hybrid/decentralized approach employed by Elligo Health Research, resulting in enhanced efficiency and rapid participant enrollment.